BE821175A - PREPARATION OF VACCINES WITH FRAGMENTS OF APYRETOGENIC VIRUSES - Google Patents
PREPARATION OF VACCINES WITH FRAGMENTS OF APYRETOGENIC VIRUSESInfo
- Publication number
- BE821175A BE821175A BE149618A BE149618A BE821175A BE 821175 A BE821175 A BE 821175A BE 149618 A BE149618 A BE 149618A BE 149618 A BE149618 A BE 149618A BE 821175 A BE821175 A BE 821175A
- Authority
- BE
- Belgium
- Prior art keywords
- apyretogenic
- vaccines
- viruses
- fragments
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
BE821175A true BE821175A (en) | 1975-04-17 |
Family
ID=10449549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE149618A BE821175A (en) | 1973-10-18 | 1974-10-17 | PREPARATION OF VACCINES WITH FRAGMENTS OF APYRETOGENIC VIRUSES |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5082228A (en) |
AT (1) | AT334524B (en) |
BE (1) | BE821175A (en) |
CA (1) | CA1050886A (en) |
CH (1) | CH611518A5 (en) |
DE (1) | DE2449530C2 (en) |
DK (1) | DK138581B (en) |
FR (1) | FR2248054B1 (en) |
GB (1) | GB1486557A (en) |
IE (1) | IE40187B1 (en) |
IL (1) | IL45870A (en) |
NL (1) | NL181553C (en) |
NO (1) | NO142024C (en) |
SE (1) | SE426439B (en) |
ZA (1) | ZA746398B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK276380A (en) * | 1979-07-09 | 1981-01-10 | Univ Iowa State Res Found Inc | PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST INFECTIOUS KVEG-RHINOTRACHEITIS |
FR2470795A1 (en) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | PROCESS FOR THE PURIFICATION OF PARTICLES OF BIOLOGICAL ORIGIN, IN PARTICULAR OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS (AGHBS) AND THE PRODUCTS OBTAINED |
FR2475572A1 (en) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | PROCESS FOR OBTAINING LIPID ENVELOPE VIRUS FRAGMENTS, PARTICULARLY ANTIGENS USED AS VACCINES, PRODUCTS OBTAINED AND APPLICATIONS |
FR2483779A1 (en) | 1980-06-05 | 1981-12-11 | Synthelabo | PROCESS FOR ISOLATING VIRAL GLYCOPROTETIC ANTIGENS AND APPLICATION THEREOF TO VACCINE PREPARATION |
DE19938767C2 (en) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | subunit vaccines |
MXPA03002890A (en) * | 2000-10-02 | 2004-12-03 | Glaxosmithkline Biolog Sa | Vaccine. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1973
- 1973-10-18 GB GB48685/73A patent/GB1486557A/en not_active Expired
-
1974
- 1974-10-08 ZA ZA00746398A patent/ZA746398B/en unknown
- 1974-10-17 CH CH1394974A patent/CH611518A5/en not_active IP Right Cessation
- 1974-10-17 BE BE149618A patent/BE821175A/en not_active IP Right Cessation
- 1974-10-17 DK DK543974AA patent/DK138581B/en not_active IP Right Cessation
- 1974-10-17 CA CA211,654A patent/CA1050886A/en not_active Expired
- 1974-10-17 NO NO743758A patent/NO142024C/en unknown
- 1974-10-17 SE SE7413113A patent/SE426439B/en unknown
- 1974-10-17 IL IL45870A patent/IL45870A/en unknown
- 1974-10-17 JP JP49119836A patent/JPS5082228A/ja active Pending
- 1974-10-17 IE IE2141/74A patent/IE40187B1/en unknown
- 1974-10-17 AT AT835074A patent/AT334524B/en not_active IP Right Cessation
- 1974-10-17 DE DE2449530A patent/DE2449530C2/en not_active Expired
- 1974-10-17 NL NLAANVRAGE7413642,A patent/NL181553C/en not_active IP Right Cessation
- 1974-10-18 FR FR7435179A patent/FR2248054B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2248054A1 (en) | 1975-05-16 |
NO743758L (en) | 1975-05-12 |
CA1050886A (en) | 1979-03-20 |
ZA746398B (en) | 1976-06-30 |
DK138581B (en) | 1978-10-02 |
NL7413642A (en) | 1975-04-22 |
FR2248054B1 (en) | 1978-07-28 |
NL181553B (en) | 1987-04-16 |
DE2449530C2 (en) | 1985-08-08 |
NL181553C (en) | 1987-09-16 |
NO142024B (en) | 1980-03-10 |
AU7444974A (en) | 1976-04-29 |
JPS5082228A (en) | 1975-07-03 |
IE40187B1 (en) | 1979-03-28 |
GB1486557A (en) | 1977-09-21 |
ATA835074A (en) | 1976-05-15 |
IL45870A0 (en) | 1974-12-31 |
DK543974A (en) | 1975-06-16 |
AT334524B (en) | 1976-01-25 |
CH611518A5 (en) | 1979-06-15 |
SE7413113L (en) | 1975-04-21 |
DE2449530A1 (en) | 1975-04-30 |
DK138581C (en) | 1979-03-12 |
IE40187L (en) | 1975-04-18 |
NO142024C (en) | 1980-06-18 |
SE426439B (en) | 1983-01-24 |
IL45870A (en) | 1978-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE388542B (en) | PROCEDURE FOR THE PREPARATION OF A VIRUS HEPATIT VACCINE | |
OA04704A (en) | Process for the preparation of new vaccines. | |
BE805570A (en) | VACCINES AND THEIR PREPARATION | |
BE787901A (en) | ANTIVARIOLIC VACCINE | |
BE810697A (en) | VIRUS INACTIVATION | |
BE821175A (en) | PREPARATION OF VACCINES WITH FRAGMENTS OF APYRETOGENIC VIRUSES | |
ZA745571B (en) | Live influenza virus vaccines and preparation thereof | |
BE832967A (en) | VACCINES AGAINST ENTERITES | |
BE822736A (en) | INFLUENZA VACCINES | |
BE824372A (en) | INFLUENZA VACCINES AND PROCEDURE FOR THEIR PREPARATION | |
GB1538704A (en) | Inactivated equine rhinopneumonitis virus vaccine | |
CH611338A5 (en) | Process for the preparation of inactivated HB-Ag vaccines | |
AU502636B2 (en) | Vaccine from attenuated virus | |
CA962593A (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
IL46446A0 (en) | Live influenza type b virus vaccines and preparation thereof | |
FR2314252A1 (en) | VIRUS VACCINE PREPARATION PROCESS | |
AR201878A1 (en) | PROCEDURE TO PREPARE AN IMMUNIZING AND NON-PATHOGENIC VACCINE | |
AU494835B2 (en) | Live influenza type b virus vaccines and preparation thereof | |
IL52222A (en) | Live influenza virus vaccine and preparation thereof | |
AU494738B2 (en) | Virus subunit vaccine | |
AU497239B2 (en) | Parainfluenza virus vaccine | |
AU7946675A (en) | Vaccine from attenuated virus | |
AR193480A1 (en) | PROCEDURE FOR MASS CULTURE OF GLOPOPEDA VIRUSES | |
BR6912019D0 (en) | VACCINE FOR MOUTH MOLDING FEVER FROM DEAD VIRUSES | |
CA813864A (en) | Influenza virus sub-unit vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: EVANS MEDICAL LTD Effective date: 19941017 |